Skip to main content
$5.93 $0.06 (1.0%)

04:00 PM EDT on 07/30/21

Flexion Therapeutics (NASDAQ:FLXN)

CAPS Rating: 2 out of 5

Current Price $5.93 Mkt Cap $296.2M
Open $5.89 P/E Ratio 0.00
Prev. Close $5.93 Div. (Yield) $0.00 (0.0%)
Daily Range $5.85 - $6.12 Volume 536,597
52-Wk Range $5.84 - $13.78 Avg. Daily Vol. 611,335

Caps

How do you think NASDAQ:FLXN will perform against the market?

Add Stock to CAPS Watchlist

All Players

19 Outperform
3 Underperform
 

All-Star Players

8 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:FLXN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NoPlaceLikeHome (73.06)
Submitted March 09, 2017

With a phase 3 trial that can support an FDA application for approval of Zilretta, a non-opioid therapy for knee pain in osteoarthritis patients, under their belt, they are on the road to final approval. Long story short, if it gets the FDA green… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:FLXN VS S&P 500 (SPY)

NASDAQ:FLXN Summary

Recent Community Commentary

Read the most recent pitches from players about FLXN.

Recs

0
Member Avatar EKO01 (69.00) Submitted: 6/18/2020 3:52:08 PM : Outperform Start Price: $12.66 NASDAQ:FLXN Score: -93.25

Flexion is one of the best small caps in the pharmaceutical space. with zilretta approaches pathologies and pains of the knee and shoulder with a new approach, through non-cortisone-based polymer. good foundations for robust growth given patient numbers in the USA.

Recs

0
Member Avatar TheCapo (< 20) Submitted: 10/30/2017 3:02:32 PM : Outperform Start Price: $22.52 NASDAQ:FLXN Score: -144.40

umm .. read current analysis. been following for months .. plus timing is right with anti-opiods politics ..

Recs

0
Member Avatar TMFEBCapital (97.48) Submitted: 10/5/2017 10:14:52 AM : Outperform Start Price: $26.56 NASDAQ:FLXN Score: -150.48

I want to watch what happens with this one. PDUFA date for its osteoarthritis pain of the knee drug -- Zilretta -- tomorrow. I lean toward an OK, but anything can happen. This is binary. Approval could lead to 9-figures in sales, rejection could cause this stock to lose most of its value. Very high risk stock with catalyst.

Leaderboard

Find the members with the highest scoring picks in FLXN.

Score Leader

Reallynow222

Reallynow222 (90.42) Score: +152.48

The Score Leader is the player with the highest score across all their picks in FLXN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
WildShaman 81.37 7/9/2018 Underperform 5Y $26.32 -77.47% +58.58% +136.04 0 Comment
Antigreen < 20 5/11/2020 Underperform 5Y $10.01 -40.76% +51.05% +91.81 0 Comment
BogotaClub 29.14 7/30/2020 Underperform 5Y $12.90 -54.03% +36.23% +90.26 0 Comment
NextGenStock 64.85 5/21/2021 Outperform 5Y $8.59 -30.97% +5.45% -36.41 0 Comment
drugtrader 85.68 12/14/2020 Outperform 5Y $11.08 -46.48% +18.96% -65.44 0 Comment
stereotyp72 78.30 11/23/2020 Outperform 5Y $11.05 -46.33% +22.77% -69.10 0 Comment
EKO01 69.00 6/23/2020 Outperform 1Y $12.66 -53.16% +40.09% -93.25 1 Comment
portefeuille 98.49 4/29/2019 Outperform 5Y $10.79 -45.04% +49.41% -94.45 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. MarkBiotech < 20 1/24/2018 Outperform 5Y $23.60 -74.87% +55.19% -130.06 0 Comment
jcolson15 45.83 2/12/2018 Outperform 5Y $22.04 -73.09% +66.22% -139.32 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for FLXN.